In this respect, the presence of elevated IL-26 and/or IL-17 A concentrations in our cohort was not distinctly associated with asthma or specific allergic disease, but rather emerge as general biomarkers of an inflammation that has traditionally been regarded as mediated by Type 2 cytokines. Here, IL17A is linked to asthma.